Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 250
  • Start Date: February 2021
COVID Vaccination in Rare and Complex Connective Tissue Diseases: ERN ReCONNET Multicentre Prospective Cohort Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: January 2021
Belimumab Treatment for IgG4-related Disease, a Prospective, Open-label Clinical Trial
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: January 2021
A Phase II, Single-Site, Open-Label Study of Zanubrutinib in Patients With IgG4-Related Disease
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Other, Drug
  • Participants: 160
  • Start Date: October 26, 2020
A Phase 3, Randomized, Double-blind, Multicenter, Placebo Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: September 1, 2020
Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 25
  • Start Date: August 21, 2020
An Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patients With IgG4-Related Disease
Clinical Trial
  • Status: Recruiting
  • Participants: 660
  • Start Date: June 10, 2020
Detection of Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4 Related Diseases
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: November 1, 2019
Characterizing IgG4-related Disease With 68Ga-FAPI PET/CT
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 138
  • Start Date: October 15, 2019
Evaluation and Prediction of Relapse Risk After Glucocorticoid and Immunosuppressant Withdrawal in Patients With Stable IgG4 Related Disease: An Open-labeled Multi-centric Randomized Controlled Study From China
Clinical Trial
  • Status: Recruiting
  • Participants: 900
  • Start Date: December 2016
National Registry of IgG4-RD in China
Clinical Trial
  • Status: Recruiting
  • Participants: 300
  • Start Date: November 2015
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Clinical Trial
  • Status: Recruiting
  • Participants: 1000
  • Start Date: January 2012
Cohort Study of Patients With IgG4-Related Disease
Showing 1-12 of 12